Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis

ClinicalTrials.gov ID: NCT03824405

Public ClinicalTrials.gov record NCT03824405. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 1:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis

Study identification

NCT ID
NCT03824405
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Botanix Pharmaceuticals
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

  • BTX 1204 Drug
  • Vehicle Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 3, 2019
Primary completion
Jan 26, 2020
Completion
Mar 3, 2020
Last update posted
Oct 24, 2022

2019 – 2020

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Applied Research Center of Arkansas Inc. Little Rock Arkansas 72212
T. Joseph Raoff MD Inc. / Encino Research Center Encino California 91436
Center for Dermatology Clinical Research Fremont California 94538
Dermatology Specialist Inc. - Murrieta Murrieta California 92562
Rady Childern's Hospital - San Diego San Diego California 92123
Clinical Science Institute Santa Monica California 90404
Precision Clinical Research Davie Florida 33328
Troy Sullivan North Miami Beach Florida 33162
DS Research Louisville Kentucky 40241
Delright Research New Orleans Louisiana 70115
Medisearch Clinical Trails Saint Joseph Missouri 64506
Washington Univerisy in St. Louis St Louis Missouri 63141
JDR Dermatology Research LLC Las Vegas Nevada 89148
The Acne Treatment and Research Center Morristown New Jersey 07960
Aventiv Research Inc - Dublin Dublin Ohio 43016
Greenville Dermatology, LLC Greenville South Carolina 29607
Dermresearch Inc Austin Texas 78759
J&S Studies Inc. College Station Texas 77845
The Center for Skin Research at Suzanne Bruce & Associates Dermatology Houston Texas 77056

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03824405, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 24, 2022 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03824405 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →